Literature DB >> 15787831

Topical liarozole in ichthyosis: a double-blind, left-right comparative study followed by a long-term open maintenance study.

G P H Lucker, C J Verfaille, A M C Heremans, F P Vanhoutte, J P J Boegheim, P P M Steijlen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15787831     DOI： 10.1111/j.1365-2133.2005.06399.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

1.  Systemic retinoids in the management of ichthyoses and related skin types.

Authors:  John J Digiovanna; Theodora Mauro; Leonard M Milstone; Matthias Schmuth; Jorge R Toro
Journal:  Dermatol Ther       Date:  2013 Jan-Feb       Impact factor: 2.851

Review 2.  Treatments for Non-Syndromic Inherited Ichthyosis, Including Emergent Pathogenesis-Related Therapy.

Authors:  Divina Justina Hasbani; Lamiaa Hamie; Edward Eid; Christel Tamer; Ossama Abbas; Mazen Kurban
Journal:  Am J Clin Dermatol       Date:  2022-08-12       Impact factor: 6.233

3.  Preclinical assessment of dual CYP26[A1/B1] inhibitor, DX308, as an improved treatment for keratinization disorders.

Authors:  J G S Veit; Y Poumay; D Mendes; J Kreitinger; L Walker; A Paquet; C Menigot; F Zolezzi; A S Paller; P Diaz
Journal:  Skin Health Dis       Date:  2021-03-26

Review 4.  Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics.

Authors:  Cara H Nelson; Brian R Buttrick; Nina Isoherranen
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

Review 5.  Characterization of CYP26B1-Selective Inhibitor, DX314, as a Potential Therapeutic for Keratinization Disorders.

Authors:  Joachim G S Veit; Valérie De Glas; Benoît Balau; Haoming Liu; Florence Bourlond; Amy S Paller; Yves Poumay; Philippe Diaz
Journal:  J Invest Dermatol       Date:  2020-06-04       Impact factor: 8.551
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.